Table 2.
TICI 2c-3 | TICI 0-2b | P-value | TICI 2b-3 | TICI 0-2a | P-value | |||||
---|---|---|---|---|---|---|---|---|---|---|
HU | n | HU | n | HU | n | HU | n | |||
First-pass outcome | 65.99 ± 8.44 | 17 | 64.56 ± 11.03 | 47 | 0.630 | 67.18 ± 9.46 | 20 | 63.92 ± 10.70 | 44 | 0.246 |
Primary SR | 71.39 ± 8.47 | 6 | 59.07 ± 12.08 | 15 | 0.035 | 69.64 ± 9.01 | 7 | 59.06 ± 12.54 | 14 | 0.062 |
Primary CA | 57.45 ± 5.22 | 5 | 66.68 ± 10.06 | 21 | 0.061 | 60.44 ± 8.69 | 6 | 66.24 ± 10.12 | 20 | 0.217 |
Primary Solumbra | 67.70 ± 4.80 | 6 | 68.00 ± 9.26 | 11 | 0.942 | 70.49 ± 8.59 | 7 | 66.07 ± 7.07 | 10 | 0.286 |
Primary strategy outcome | 65.34 ± 9.97 | 29 | 64.61 ± 10.82 | 35 | 0.781 | 66.01 ± 10.22 | 34 | 63.72 ± 10.56 | 30 | 0.383 |
Primary SR | 68.07 ± 11.10 | 9 | 58.50 ± 12.0 | 12 | 0.078 | 67.18 ± 10.84 | 10 | 58.42 ± 12.63 | 11 | 0.106 |
Primary CA | 59.91 ± 10.68 | 10 | 68.02 ± 8.34 | 16 | 0.040 | 61.98 ± 10.88 | 12 | 67.41 ± 8.70 | 14 | 0.170 |
Primary Solumbra | 68.31 ± 5.95 | 10 | 67.30 ± 10.41 | 7 | 0.802 | 69.07 ± 8.36 | 12 | 65.08 ± 6.11 | 5 | 0.353 |
Final outcome | 64.76 ± 9.22 | 49 | 65.52 ± 13.84 | 15 | 0.805 | 65.27 ± 9.42 | 57 | 62.19 ± 17.01 | 7 | 0.462 |
Primary SR | 64.38 ± 9.92 | 16 | 56.87 ± 18.45 | 5 | 0.245 | 64.07 ± 9.69 | 17 | 56.30 ± 21.26 | 4 | 0.269 |
Primary CA | 63.36 ± 10.28 | 21 | 71.39 ± 5.10 | 5 | 0.106 | 64.65 ± 10.28 | 24 | 67.90 ± 5.30 | 2 | 0.667 |
Primary Solumbra | 67.72 ± 5.56 | 12 | 68.31 ± 12.57 | 5 | 0.892 | 67.49 ± 7.87 | 16 | 74.35 | 1 | NA |
Thrombus density are shown as mean HU ± SD.
SR, stent retriever; CA, contact aspiration; Solumbra, a combination of stent retriever and aspiration; HU, Hounsfield unit; NA, not available.